Most Read This Week
- Use of SGLT2 Inhibitors Reduces Epicardial Adipose Tissue More Effectively Compared With GLP-1 Agonists or Exercise in Patients With Type 2 Diabetes and/or Obesity
- Incidence of Early-Onset Type 2 Diabetes and Sociodemographic Predictors of Complications
- Prevalence of Metabolic Syndrome Among Children and Adolescents With Obesity
- Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes — 2025
- Safety of Using Dapagliflozin Plus Metformin in Patients With Type 2 Diabetes
Recently Updated
- GLP-1 RAs Efficacious for Weight Loss in Overweight, Obesity Without Diabetes
- Participation in National Diabetes Prevention Program Is Cost-Saving
- Proteins Associated With Social Isolation, Loneliness Identified
- Disparities Exist in Use of Obesity-Management Medications
- Late Eating Tied to Poor Glucose Tolerance